Ardelyx Inc (ARDX)
8.48
-0.83
(-8.92%)
USD |
NASDAQ |
May 08, 16:00
8.45
-0.03
(-0.35%)
Pre-Market: 08:09
Ardelyx 1 Year Total Returns (Daily): 102.4% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 08, 2024 | 102.4% |
| May 07, 2024 | 102.0% |
| May 06, 2024 | 98.48% |
| May 03, 2024 | 86.32% |
| May 02, 2024 | 52.93% |
| May 01, 2024 | 42.15% |
| April 30, 2024 | 43.50% |
| April 29, 2024 | 44.84% |
| April 26, 2024 | 37.77% |
| April 25, 2024 | 36.88% |
| April 24, 2024 | 36.23% |
| April 23, 2024 | 29.09% |
| April 22, 2024 | 31.52% |
| April 19, 2024 | 32.24% |
| April 18, 2024 | 31.70% |
| April 17, 2024 | 33.13% |
| April 16, 2024 | 42.46% |
| April 15, 2024 | 44.37% |
| April 12, 2024 | 56.89% |
| April 11, 2024 | 60.22% |
| April 10, 2024 | 67.37% |
| April 09, 2024 | 62.95% |
| April 08, 2024 | 66.36% |
| April 05, 2024 | 69.30% |
| April 04, 2024 | 58.76% |
| Date | Value |
|---|---|
| April 03, 2024 | 55.72% |
| April 02, 2024 | 53.24% |
| April 01, 2024 | 54.70% |
| March 28, 2024 | 72.99% |
| March 27, 2024 | 71.53% |
| March 26, 2024 | 85.50% |
| March 25, 2024 | 92.50% |
| March 22, 2024 | 96.43% |
| March 21, 2024 | 89.13% |
| March 20, 2024 | 101.0% |
| March 19, 2024 | 98.02% |
| March 18, 2024 | 93.58% |
| March 15, 2024 | 103.0% |
| March 14, 2024 | 103.3% |
| March 13, 2024 | 131.6% |
| March 12, 2024 | 136.5% |
| March 11, 2024 | 138.5% |
| March 08, 2024 | 113.5% |
| March 07, 2024 | 127.7% |
| March 06, 2024 | 144.4% |
| March 05, 2024 | 151.0% |
| March 04, 2024 | 136.6% |
| March 01, 2024 | 219.9% |
| February 29, 2024 | 223.6% |
| February 28, 2024 | 228.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.12%
Minimum
Jun 14 2022
688.1%
Maximum
Jun 14 2023
81.48%
Average
24.18%
Median
Sep 18 2020
1 Year Total Returns (Daily) Benchmarks
| Nektar Therapeutics | 113.0% |
| Rigel Pharmaceuticals Inc | -16.61% |
| Omeros Corp | -29.40% |
| Vistagen Therapeutics Inc | 17.17% |
| Karyopharm Therapeutics Inc | -59.20% |